KIF6 rs20455: What Your Genotype Means for Statin Therapy
The rs20455 variant is a single nucleotide polymorphism located in the KIF6 gene. It has been studied for its potential association with cardiovascular disease risk and how individuals may respond to statin therapy.
What each genotype means
Homozygous for Arg719 variant
This genotype results in the presence of the 719Arg variant in the KIF6 protein. While some early research suggested this variant might influence cardiovascular risk or statin response, subsequent large-scale clinical trials have not consistently supported these associations. Please discuss your cardiovascular health and any medication plans with your clinician.
This genotype is common, with the C allele (Arg719) present in approximately 35% of individuals of European ancestry.
Heterozygous for KIF6 variant
You carry one copy of the 719Arg variant and one copy of the 719Trp variant. Large-scale studies have generally found no significant impact of this genotype on cardiovascular disease risk or the effectiveness of statin therapy. You should consult with your healthcare provider regarding your specific heart health needs and treatment options.
This heterozygous genotype is frequently observed in populations where the C allele is common, such as in European cohorts.
Homozygous for Trp719 variant
This genotype represents the 719Trp variant of the KIF6 gene. Research indicates that this genotype does not significantly alter cardiovascular risk or the response to statin therapy compared to other genotypes. Always consult your pharmacist or doctor to determine the most appropriate cardiovascular management strategy for your health profile.
This genotype is common across many global populations, representing the alternative allele to the 719Arg variant.
Understanding the rs20455 Variant
The rs20455 variant is a specific change in the DNA sequence of the KIF6 gene, often referred to as the Trp719Arg polymorphism. In this variant, a single nucleotide substitution results in the replacement of the amino acid tryptophan with arginine at position 719 of the KIF6 protein. This type of change is known as a missense mutation. Because this variant is located within the coding region of the gene, it has the potential to alter the structure or function of the resulting protein. Researchers have spent years investigating whether this specific change influences how the body interacts with medications, particularly statins, which are commonly prescribed to manage cholesterol levels and reduce the risk of heart-related events.
The Role of the KIF6 Gene
The KIF6 gene encodes the kinesin family member 6 protein. Kinesins are a group of motor proteins that play a critical role in intracellular transport, moving various cellular components along microtubules within the cell. While the exact biological function of the KIF6 protein in the context of cardiovascular health remains a subject of ongoing research, its membership in the kinesin superfamily suggests it is involved in essential cellular maintenance and transport processes. Despite its identification as a potential pharmacogenetic marker, the precise mechanism by which KIF6 variants might influence cardiovascular outcomes or drug efficacy is not yet fully understood. Scientists continue to study this gene to determine if it plays a direct role in the pathogenesis of coronary heart disease or if it serves as a marker for other underlying biological processes.
Research on Statin Therapy and Cardiovascular Risk
The association between rs20455 and statin therapy has been a topic of significant scientific debate. Early studies suggested that individuals carrying the arginine (Arg) allele might experience a greater reduction in cardiovascular risk when treated with statins compared to non-carriers. However, subsequent large-scale clinical trials and meta-analyses have produced conflicting results, with some studies finding no consistent evidence that this variant predicts a differential response to statin treatment. Because the evidence is mixed and inconsistent across different populations and clinical settings, the clinical utility of testing for this variant remains limited. It is important to recognize that cardiovascular health is influenced by a complex interplay of many genetic factors, lifestyle choices, and environmental influences, rather than a single genetic variant.
Interpreting Your Genetic Information
If you have information about your rs20455 genotype, it is essential to view it within the context of current medical consensus. Because the scientific community has not reached a definitive conclusion regarding the impact of this variant on statin efficacy, this information should not be used to make independent decisions about your medication. Genetic testing results for rs20455 are not a substitute for professional medical advice. If you are concerned about your cardiovascular health or the effectiveness of your current treatment plan, you should discuss these findings with your clinician or a pharmacist. They can help you interpret your results in light of your overall health profile, medical history, and established clinical guidelines for managing cholesterol and heart disease risk.
How common is this variant?
The rs20455 variant is relatively common, with the minor allele frequency reported at approximately 35% in European populations.
Frequently asked questions
Does the KIF6 rs20455 variant mean I should change my statin dose?
No. You should never change your medication dosage based on genetic test results without consulting your doctor. Current evidence is inconsistent, and clinical decisions should be based on established medical guidelines.
Is KIF6 testing recommended for everyone?
No. Major medical organizations do not currently recommend routine KIF6 genotyping for the general population. The clinical utility of this test for predicting statin response is not well-established.
What does it mean if I am a carrier of the Arg allele?
Being a carrier means you have at least one copy of the arginine variant. While some studies have explored its link to statin response, the findings are mixed and do not provide a clear clinical directive.
Where can I find more information about KIF6 and heart health?
You can consult resources like MedlinePlus Genetics or the PubMed database for peer-reviewed research. Always discuss any specific health concerns with your primary care physician or a cardiologist.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs20455?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in KIF6
Associated with variation in the upper face contour and forehead shape in European cohorts.
Intronic variant within KIF6 associated with human facial shape morphology and craniofacial proportion variation.
Variant within the KIF6 genomic locus significantly associated with normal human facial morphology and shape variation.